Robert A. Bailey

1.2k total citations
47 papers, 832 citations indexed

About

Robert A. Bailey is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Robert A. Bailey has authored 47 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Nephrology and 8 papers in Surgery. Recurrent topics in Robert A. Bailey's work include Diabetes Treatment and Management (19 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (7 papers). Robert A. Bailey is often cited by papers focused on Diabetes Treatment and Management (19 papers), Diabetes Management and Research (16 papers) and Pancreatic function and diabetes (7 papers). Robert A. Bailey collaborates with scholars based in United States, Canada and Belgium. Robert A. Bailey's co-authors include Marcia F.T. Rupnow, Vivienne J. Zhu, Yi‐Ting Wang, Janice Lopez, Patrick Lefèbvre, Mei Sheng Duh, K. Annunziata, Brahim Bookhart, Alicia C. Shillington and Martha M. Funnell and has published in prestigious journals such as Blood, American Journal of Psychiatry and Diabetes Care.

In The Last Decade

Robert A. Bailey

45 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Bailey United States 16 401 198 147 103 95 47 832
Ross Ward United Kingdom 8 286 0.7× 208 1.1× 156 1.1× 91 0.9× 80 0.8× 18 944
Jelka Zaletel Slovenia 11 254 0.6× 234 1.2× 116 0.8× 250 2.4× 105 1.1× 32 841
Mats Bojestig Sweden 15 512 1.3× 245 1.2× 180 1.2× 51 0.5× 110 1.2× 19 979
Anouk Déruaz‐Luyet United States 16 424 1.1× 94 0.5× 157 1.1× 224 2.2× 116 1.2× 52 765
Chih‐Cheng Hsu Taiwan 16 181 0.5× 257 1.3× 107 0.7× 163 1.6× 51 0.5× 56 801
John Dean United Kingdom 14 255 0.6× 92 0.5× 114 0.8× 88 0.9× 238 2.5× 35 867
Vivienne J. Zhu United States 13 220 0.5× 91 0.5× 76 0.5× 148 1.4× 71 0.7× 24 784
Sayan Cheepudomwit Thailand 6 366 0.9× 270 1.4× 82 0.6× 209 2.0× 33 0.3× 13 722
Griët Bos Netherlands 9 154 0.4× 301 1.5× 129 0.9× 103 1.0× 76 0.8× 10 798
Joel E. Segel United States 18 457 1.1× 253 1.3× 265 1.8× 207 2.0× 176 1.9× 61 1.4k

Countries citing papers authored by Robert A. Bailey

Since Specialization
Citations

This map shows the geographic impact of Robert A. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Bailey more than expected).

Fields of papers citing papers by Robert A. Bailey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Bailey. The network helps show where Robert A. Bailey may publish in the future.

Co-authorship network of co-authors of Robert A. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Bailey. A scholar is included among the top collaborators of Robert A. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Bailey. Robert A. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henderson, Ralph J., et al.. (2024). Integrating Broad Panel Somatic and Germline Testing in Prostate Cancer Care. JU Open Plus. 2(12).
2.
Stempniewicz, Nikita, Joseph A. Vassalotti, John K. Cuddeback, et al.. (2021). Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations. Diabetes Care. 44(9). 2000–2009. 81 indexed citations
3.
Rodríguez, Fátima, Joseph Vasey, Robert A. Bailey, et al.. (2021). Real-World Diagnosis and Treatment of Diabetic Kidney Disease. Advances in Therapy. 38(8). 4425–4441. 22 indexed citations
4.
Young, James B., Marjolaine Gauthier‐Loiselle, Robert A. Bailey, et al.. (2018). Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data. Cardiovascular Diabetology. 17(1). 118–118. 31 indexed citations
5.
6.
Bailey, Robert A., Phil Schwab, Yihua Xu, Margaret K. Pasquale, & Andrew Renda. (2016). Glycemic Control Outcomes After Canagliflozin Initiation: Observations in a Medicare and Commercial Managed Care Population in Clinical Practice. Clinical Therapeutics. 38(9). 2046–2057.e2. 5 indexed citations
7.
Chow, Wing, et al.. (2016). Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus—A Multi-Database Synthesis. Clinical Therapeutics. 38(9). 2071–2082. 5 indexed citations
8.
Patel, Charmi, Robert A. Bailey, Ujjwala Vijapurkar, Gary Meininger, & Lawrence Blonde. (2016). A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures. BMC Health Services Research. 16(1). 356–356. 6 indexed citations
9.
Bailey, Robert A., Michael Pfeifer, Alicia C. Shillington, et al.. (2015). Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict. BMC Health Services Research. 16(1). 10–10. 64 indexed citations
10.
Meckley, Lisa M., et al.. (2015). Real-world canagliflozin utilization: Impact on glycemic control in Patients with Type 2 diabetes mellitus. Value in Health. 18(3). A54–A55. 2 indexed citations
11.
Bailey, Robert A., Ujjwala Vijapurkar, Gary Meininger, Marcia F.T. Rupnow, & Lawrence Blonde. (2014). Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.. PubMed. 20(13 Suppl). s296–305. 16 indexed citations
12.
Bailey, Robert A., Yi‐Ting Wang, Vivienne J. Zhu, & Marcia F.T. Rupnow. (2014). Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Research Notes. 7(1). 415–415. 182 indexed citations
13.
Lopez, Janice, Robert A. Bailey, Marcia F.T. Rupnow, & K. Annunziata. (2014). Characterization of Type 2 Diabetes Mellitus Burden by Age and Ethnic Groups Based on a Nationwide Survey. Clinical Therapeutics. 36(4). 494–506. 50 indexed citations
14.
15.
Bailey, Robert A., et al.. (2012). Association of anemia with worsened activities of daily living and health-related quality of life scores derived from the Minimum Data Set in long-term care residents. Health and Quality of Life Outcomes. 10(1). 129–129. 22 indexed citations
16.
Lafeuille, Marie‐Hélène, et al.. (2010). Drug Utilization and Cost for Erythropoiesis-Stimulating Agents in a Long-Term Care Resident Population with Chronic Kidney Disease. The Consultant Pharmacist. 25(8). 493–500.
17.
Laliberté, François, Brahim Bookhart, Francis Vekeman, et al.. (2009). Direct All-Cause Health Care Costs Associated With Chronic Kidney Disease in Patients With Diabetes and Hypertension: A Managed Care Perspective. Journal of Managed Care Pharmacy. 15(4). 312–322. 61 indexed citations
18.
Bailey, Robert A.. (1999). Care of Chronically Mentally Ill Patients in a Managed Care Environment. American Journal of Psychiatry. 156(11). 1801–1806. 2 indexed citations
19.
Kaplan, André A., et al.. (1996). High Flux Plasma Exchange Using a Modified Rotating Membrane System. ASAIO Journal. 42(6). 957–960. 3 indexed citations
20.
Bailey, Robert A.. (1960). Summer frosts: a factor in plant range and timber succession. 7(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross Ward Breakdown of academic impact, for papers by Jelka Zaletel Breakdown of academic impact, for papers by Mats Bojestig Breakdown of academic impact, for papers by Anouk Déruaz‐Luyet Breakdown of academic impact, for papers by Chih‐Cheng Hsu Breakdown of academic impact, for papers by John Dean Breakdown of academic impact, for papers by Vivienne J. Zhu Breakdown of academic impact, for papers by Sayan Cheepudomwit Breakdown of academic impact, for papers by Griët Bos Breakdown of academic impact, for papers by Joel E. Segel
Rankless by CCL
2026